UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 21, 2024
| Kaya Holdings, Inc. |
| (Exact name of registrant as specified in its charter) |
| Delaware | | 333-177532 | | 90-0898007 |
| (State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
915 Middle River Drive, Suite 316, Fort Lauderdale, FL | | | 33304 | |
| (Address of principal executive offices) | | | (Zip Code) | |
| Registrant’s telephone number including area code: (954) 480-1270 |
| (Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of Company under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| None | | |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
As used in this Current Report on Form 8-K (the “Report ”), the terms “KAYS,” the “Company,” “we ,” “us” and “our” refer to Kaya Holdings, Inc. and its owned and controlled subsidiaries, unless the context indicates otherwise.
Item 7.01 Regulation FD Disclosure.
The following is a link to a story broadcast by television station KATU in Portland, Oregon about the Company’s recently launched psilocybin treatment center, The Sacred Mushroom™:
https://www.dropbox.com/scl/fi/0pncy7lp5o3j2yl5r9kpb/TSM-08252024.mp4?rlkey=268b017cuymzyyqf08gbkbl1w&st=cfi6wkpp&dl=0
The foregoing information, including the news story broadcast by KATU, is being furnished pursuant to Item 7.01 of this Report and shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended or incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| Dated: August 26, 2024 | KAYA HOLDINGS, INC. |
| | | |
| | By: | /s/ Craig Frank |
| | | Craig Frank, Chief Executive Officer |
